The role of environmental factors in modulating immune responses in early life

Frontiers in Immunology

Volumn 5, Issue SEP, 2014, Pages

  MacGillivray, Duncan M ^a   Kollmann, Tobias R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Environment; Evolution; Immune system; Immunologic memory; Innate immunity; Ontogeny; Pediatrics

Indexed keywords

POLYCHLORINATED BIPHENYL; TERATOGENIC AGENT; TRACE ELEMENT;

ADAPTIVE IMMUNITY; ANTIGEN SPECIFICITY; BREAST FEEDING; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; HUMAN; HYGIENE HYPOTHESIS; IMMUNOLOGICAL MEMORY; IMMUNOMODULATION; INNATE IMMUNITY; MACRONUTRIENT; MICROBIAL COLONIZATION; MICROFLORA; NEWBORN INFECTION; NONHUMAN; NUTRITIONAL STATUS; ONTOGENY; OUTCOME ASSESSMENT; PHENOTYPIC PLASTICITY; PREGNANCY; PRENATAL EXPOSURE; REVIEW; SEASONAL VARIATION;

EID: 84919451917     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00434     Document Type: Review

References (177)

1. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell (2008) 132(4):631-44. doi:10.1016/j.cell.2008.01.025
2. Cumano A, Dieterlen-Lievre F, Godin I. Lymphoid potential, probed before circulation in mouse, is restricted to caudal intraembryonic splanchnopleura. Cell (1996) 86(6):907-16. doi:10.1016/S0092-8674(00)80166-X
3. Cumano A, Ferraz JC, Klaine M, Di Santo JP, Godin I. Intraembryonic, but not yolk sac hematopoietic precursors, isolated before circulation, provide long-term multilineage reconstitution. Immunity (2001) 15(3):477-85. doi:10.1016/S1074-7613(01)00190-X
4. Tavian M, Robin C, Coulombel L, Péault B. The human embryo, but not its yolk sac, generates lympho-myeloid stem cells: mapping multipotent hematopoietic cell fate in intraembryonic mesoderm. Immunity (2001) 15(3):487-95. doi:10.1016/S1074-7613(01)00193-5
5. Zambidis ET, Oberlin E, Tavian M, Péault B. Blood-forming endothelium in human ontogeny: lessons from in utero development and embryonic stem cell culture. Trends Cardiovasc Med (2006) 16(3):95-101. doi:10.1016/j.tcm.2006.01.005
6. Sieweke MH, Allen JE. Beyond stem cells: self-renewal of differentiated macrophages. Science (2013) 342(6161):1242974-1242974. doi:10.1126/science.1242974
7. Ghazal P, Dickinson P, Smith CL. Early life response to infection. Curr Opin Infect Dis (2013) 26(3):213-8. doi:10.1097/QCO.0b013e32835fb8bf
8. Kollmann TR, Crabtree J, Rein-Weston A, Blimkie D, Thommai F, Wang XY, et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol (2009) 183(11):7150-60. doi:10.4049/jimmunol.0901481
9. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol (2007) 7(5):379-90. doi:10.1038/nri2075
10. Kollmann T, Wilson C. Induction of antigen-specific immunity in human neonates and infants. In: Barker DJP, Bergmann R, Ogra PL, editors. The Window of Opportunity: Pre-Pregnancy to 24 Months of Age. (Vol. 61), Basel: Karger (2008). p. 183-95.
11. Wynn JL, Levy O. Role of innate host defenses in susceptibility to early- onset neonatal sepsis. Clin Perinatol (2010) 37(2):307-37. doi:10.1016/j.clp.2010.04.001
12. Corbett NP, Blimkie D, Ho KC, Cai B, Sutherland DP, Kallos A, et al. Ontogeny of toll-like receptor mediated cytokine responses of human blood mononuclear cells. PLoS One (2010) 5(11):e15041. doi:10.1371/journal.pone.0015041
13. Kollmann TR, Levy O, Montgomery RR, Goriely S. Innate immune function by toll-like receptors: distinct responses in newborns and the elderly. Immunity (2012) 37(5):771-83. doi:10.1016/j.immuni.2012.10.014
14. Wadhwa P, Buss C, Entringer S, Swanson J. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med (2009) 27(05):358-68. doi:10.1055/s-0029-1237424
15. Barouki R, Gluckman PD, Grandjean P, Hanson M, Heindel JJ. Developmental origins of non-communicable disease: implications for research and public health. Environ Health (2012) 11:42. doi:10.1186/1476-069X-11-42
16. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet (2007) 8(4):253-62. doi:10.1038/nrg2045
17. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol (2010) 28(10):1057-68. doi:10.1038/nbt.1685
18. Netea MG, Quintin J, van der Meer JW. Trained immunity: a memory for innate host defense. Cell Host Microbe (2011) 9(5):355-61. doi:10.1016/j.chom.2011.04.006
19. Bruniquel D, Schwartz RH. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol (2003) 4(3):235-40. doi:10.1038/ni887
20. Northrop JK, Thomas RM, Wells AD, Shen H. Epigenetic remodeling of the IL-2 and IFN- loci in memory CD8 T cells is influenced by CD4 T cells. J Immunol (2006) 177(2):1062-9. doi:10.4049/jimmunol.177.2.1062
21. Duramad P, Tager IB, Holland NT. Cytokines and other immunological biomarkers in children's environmental health studies. Toxicol Lett (2007) 172(1):48-59. doi:10.1016/j.toxlet.2007.05.017
22. Cabassi E. The immune system and exposure to xenobiotics in animals. Vet Res Commun (2007) 31(S1):115-20. doi:10.1007/s11259-007-0074-8
23. Gundacker C, Hengstschlãger M. The role of the placenta in fetal exposure to heavy metals. Wien Med Wochenschr (2012) 162(9-10):201-6. doi:10.1007/s10354-012-0074-3
24. Vahter M. Effects of arsenic on maternal and fetal health. Annu Rev Nutr (2009) 29(1):381-99. doi:10.1146/annurev-nutr-080508-141102
25. Ritz B, Heinrich J, Wjst M, Wichmann E, Krause C. Effect of cadmium body burden on immune response of school children. Arch Environ Health (1998) 53(4):272-80. doi:10.1080/00039899809605708
26. Schwartz GG, Il'yasova D, Ivanova A. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care (2003) 26(2):468-70. doi:10.2337/diacare.26.2.468
27. Bose-O'Reilly S, McCarty KM, Steckling N, Lettmeier B. Mercury exposure and children's health. Curr Probl Pediatr Adolesc Health Care (2010) 40(8):186-215. doi:10.1016/j.cppeds.2010.07.002
28. Chen Z, Myers R, Wei T, Bind E, Kassim P, Wang G, et al. Placental transfer and concentrations of cadmium, mercury, lead, and selenium in mothers, newborns, and young children. J Expo Sci Environ Epidemiol (2014) 24(5):537-44. doi:10.1038/jes.2014.26
29. Belles-Isles M, Ayotte P, Dewailly E, Weber J-P, Roy R. Cord blood lymphocyte functions in newborns from a remote maritime population exposed to organochlorines and methylmercury. J Toxicol Environ Health A (2002) 65(2):165-82. doi:10.1080/152873902753396794
30. Miller TE, Golemboski KA, Ha RS, Bunn T, Sanders FS, Dietert RR. Developmental exposure to lead causes persistent immunotoxicity in Fischer 344 rats. Toxicol Sci (1998) 42(2):129-35. doi:10.1093/toxsci/42.2.129
31. Ahmed S, Ahsan KB, Kippler M, Mily A, Wagatsuma Y, Hoque AMW, et al. In utero arsenic exposure is associated with impaired thymic function in newborns possibly via oxidative stress and apoptosis. Toxicol Sci (2012) 129(2):305-14. doi:10.1093/toxsci/kfs202
32. Koestler DC, Avissar-Whiting M, Houseman EA, Karagas MR, Marsit CJ. Differential DNA methylation in umbilical cord blood of infants exposed to low levels of arsenic in utero. Environ Health Perspect (2013) 121(8):971-7. doi:10.1289/ehp.1205925
33. Dangleben NL, Skibola CF, Smith MT. Arsenic immunotoxicity: a review. Environ Health (2013) 12(1):73. doi:10.1186/1476-069X-12-73
34. Intarasunanont P, Navasumrit P, Woraprasit S, Chaisatra K, Suk WA, Mahidol C, et al. Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line. Environ Health (2012) 11(1):31. doi:10.1186/1476-069X-11-31
35. Kile ML, Baccarelli A, Hoffman E, Tarantini L, Quamruzzaman Q, Rahman M, et al. Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord blood leukocytes. Environ Health Perspect (2012) 120(7):1061-6. doi:10.1289/ehp.1104173
36. Lu K, Abo RP, Schlieper KA, Graffam ME, Levine S, Wishnok JS, et al. Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: an integrated metagenomics and metabolomics analysis. Environ Health Perspect (2014) 122(3):284-91. doi:10.1289/ehp.1307429
37. Dekoning E, Karmaus W. PCB exposure in utero and via breast milk. A review. J Expo Anal Environ Epidemiol (2000) 10:3. doi:10.1038/sj.jea.7500090
38. Fromme H, Mosch C, Morovitz M, Alba-Alejandre I, Boehmer S, Kiranoglu M, et al. Pre- and postnatal exposure to perfluorinated compounds (PFCs). Environ Sci Technol (2010) 44(18):7123-9. doi:10.1021/es101184f
39. Holladay SD. Prenatal immunotoxicant exposure and postnatal autoimmune disease. Environ Health Perspect (1999) 107(Suppl 5):687. doi:10.2307/3434328
40. Needham LL, Grandjean P, Heinzow B, Jørgensen PJ, Nielsen F, Patterson DG Jr, et al. Partition of environmental chemicals between maternal and fetal blood and tissues. Environ Sci Technol (2010) 45(3):1121-6. doi:10.1021/es1019614
41. Baccarelli A, Giacomini SM, Corbetta C, Landi MT, Bonzini M, Consonni D, et al. Neonatal thyroid function in Seveso 25 years after maternal exposure to dioxin. PLoS Med (2008) 5(7):e161. doi:10.1371/journal.pmed.0050161
42. Bruner-Tran KL, Osteen KG. Developmental exposure to TCDD reduces fertility and negatively affects pregnancy outcomes across multiple generations. Reprod Toxicol (2011) 31(3):344-50. doi:10.1016/j.reprotox.2010.10.003
43. Corsini E, Avogadro A, Galbiati V, dell'Agli M, Marinovich M, Galli CL, et al. In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs). Toxicol Appl Pharmacol (2011) 250(2):108-16. doi:10.1016/j.taap.2010.11.004
44. Grandjean P, Andersen EW, Budtz-Jørgensen E, Nielsen F, Mølbak KA, Weihe P, et al. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA (2012) 307(4):391-7. doi:10.1001/jama.2011.2034
45. Hertz-Picciotto I, Park H-Y, Dostal M, Kocan A, Trnovec T, Sram R. Prenatal exposures to persistent and non-persistent organic compounds and effects on immune system development. Basic Clin Pharmacol Toxicol (2008) 102(2):146-54. doi:10.1111/j.1742-7843.2007.00190.x
46. Heilmann C, Grandjean P, Weihe P, Nielsen F, Budtz-Jørgensen E. Reduced antibody responses to vaccinations in children exposed to polychlorinated biphenyls. PLoS Med (2006) 3(8):e311. doi:10.1371/journal.pmed.0030311
47. Glynn A, Thuvander A, Aune M, Johannisson A, Darnerud P, Ronquist G, et al. Immune cell counts and risks of respiratory infections among infants exposed pre- and postnatally to organochlorine compounds: a prospective study. Environ Health (2008) 7(1):62. doi:10.1186/1476-069X-7-62
48. Weisglas-Kuperus N, Patandin S, Berbers GA, Sas TC, Mulder PG, Sauer PJ, et al. Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environ Health Perspect (2000) 108(12):1203. doi:10.1289/ehp.001081203
49. Ogura I. Half-life of each dioxin and PCB congener in the human body. Organohalogen Compd (2004) 66:3376-80.
50. Ornoy A, Ergaz Z. Alcohol abuse in pregnant women: effects on the fetus and newborn, mode of action and maternal treatment. Int J Environ Res Public Health (2010) 7(2):364-79. doi:10.3390/ijerph7020364
51. Johnson S, Knight R, Marmer DJ, Steele RW. Immune deficiency in fetal alcohol syndrome. Pediatr Res (1981) 15(6):908-11. doi:10.1203/00006450-198106000-00005
52. Gauthier TW, Drews-Botsch C, Falek A, Coles C, Brown LAS. Maternal alcohol abuse and neonatal infection. Alcohol Clin Exp Res (2005) 29(6):1035-43. doi:10.1097/01.ALC.0000167956.28160.5E
53. Pal-Bhadra M, Bhadra U, Jackson DE, Mamatha L, Park P-H, Shukla SD. Distinct methylation patterns in histone h3 at lys-4 and lys-9 correlate with up- and down-regulation of genes by ethanol in hepatocytes. Life Sci (2007) 81(12):979-87. doi:10.1016/j.lfs.2007.07.030
54. Sathyan P, Golden HB, Miranda RC. Competing interactions between micro-RNAs determine neural progenitor survival and proliferation after ethanol exposure: evidence from an ex vivo model of the fetal cerebral cortical neuroepithelium. J Neurosci (2007) 27(32):8546-57. doi:10.1523/JNEUROSCI.1269-07.2007
55. Wilhelm-Benartzi CS, Houseman EA, Maccani MA, Poage GM, Koestler DC, Langevin SM, et al. In utero exposures, infant growth, and DNA methylation of repetitive elements and developmentally related genes in human placenta. Environ Health Perspect (2011) 120(2):296-302. doi:10.1289/ehp.1103927
56. Hofhuis W, De Jongste JC, Merkus P. Adverse health effects of prenatal and postnatal tobacco smoke exposure on children. Arch Dis Child (2003) 88(12):1086-90. doi:10.1136/adc.88.12.1086
57. Strachan DP, Cook DG. Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax (1997) 52(10):905-14. doi:10.1136/thx.52.10.905
58. Noakes PS. Maternal smoking is associated with impaired neonatal toll-like-receptor-mediated immune responses. Eur Respir J (2006) 28(4):721-9. doi:10.1183/09031936.06.00050206
59. Herberth G, Bauer M, Gasch M, Hinz D, Rãder S, Olek S, et al. Maternal and cord blood miR-223 expression associates with prenatal tobacco smoke exposure and low regulatory T-cell numbers. J Allergy Clin Immunol (2014) 133(2):543-50. doi:10.1016/j.jaci.2013.06.036
60. DeWitt JC, Peden-Adams MM, Keil DE, Dietert RR. Current status of developmental immunotoxicity: early-life patterns and testing. Toxicol Pathol (2012) 40(2):230-6. doi:10.1177/0192623311427709
61. Dietert RR. Developmental immunotoxicology: focus on health risks. Chem Res Toxicol (2009) 22(1):17-23. doi:10.1021/tx800198m
62. Trowsdale J, Betz AG. Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol (2006) 7(3):241-6. doi:10.1038/nrm1922
63. Juch H, Blaschitz A, Dohr G, Hutter H. HLA class I expression in the human placenta. Wien Med Wochenschr (2012) 162(9-10):196-200. doi:10.1007/s10354-012-0070-7
64. Carosella ED, Paul P, Moreau P, Rouas-Freiss N. HLA-G and HLA-E: fundamental and pathophysiological aspects. Immunol Today (2000) 21(11):532-4. doi:10.1016/S0167-5699(00)01707-2
65. Hunt JS. HLA-g and immune tolerance in pregnancy. FASEB J (2005) 19(7):681-93. doi:10.1096/fj.04-2078rev
66. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science (1998) 281(5380):1191-3. doi:10.1126/science.281.5380.1191
67. Rowe JH, Ertelt JM, Aguilera MN, Farrar MA, Way SS. Foxp3+ regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe (2011) 10(1):54-64. doi:10.1016/j.chom.2011.06.005
68. Robinson DP, Klein SL. Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav (2012) 62(3):263-71. doi:10.1016/j.yhbeh.2012.02.023
69. de Man YA, Dolhain RJEM, van de Geijn FE, Willemsen SP, Hazes JMW. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum (2008) 59(9):1241-8. doi:10.1002/art.24003
70. Østensen M, Villiger PM, Förger F. Interaction of pregnancy and autoimmune rheumatic disease. Spec Issue Gend Sex Horm Pregnancy Autoimmun (2012) 11(6-7):A437-46. doi:10.1016/j.autrev.2011.11.013
71. Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med (2014) 370(23):2211-8. doi:10.1056/NEJMra1213566
72. Sappenfield E, Jamieson DJ, Kourtis AP. Pregnancy and susceptibility to infectious diseases. Infect Dis Obstet Gynecol (2013) 2013:1-8. doi:10.1155/2013/752852
73. Beeson JG, Brown GV, Molyneux ME, Mhango C, Dzinjalamala F, Rogerson SJ. Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. J Infect Dis (1999) 180(2):464-72. doi:10.1086/314899
74. Mens PF, Bojtor EC, Schallig HD. Molecular interactions in the placenta during malaria infection. Eur J Obstet Gynecol Reprod Biol (2010) 152(2):126-32. doi:10.1016/j.ejogrb.2010.05.013
75. Kraus TA, Engel SM, Sperling RS, Kellerman L, Lo Y, Wallenstein S, et al. Characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (VIP) study. J Clin Immunol (2012) 32(2):300-11. doi:10.1007/s10875-011-9627-2
76. Robbins JR, Bakardjiev AI. Pathogens and the placental fortress. Curr Opin Microbiol (2012) 15(1):36-43. doi:10.1016/j.mib.2011.11.006
77. Strunk T, Currie A, Simmer K, Burgner D. Chronic maternal infections during pregnancy. Lancet Infect Dis (2012) 12(10):747-8. doi:10.1016/S1473-3099(12)70228-1
78. Dauby N, Goetghebuer T, Kollmann TR, Levy J, Marchant A. Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections. Lancet Infect Dis (2012) 12(4):330-40. doi:10.1016/S1473-3099(11)70341-3
79. LaBeaud AD, Malhotra I, King MJ, King CL, King CH. Do antenatal parasite infections devalue childhood vaccination? PLoS Negl Trop Dis (2009) 3(5):e442. doi:10.1371/journal.pntd.0000442
80. Lammie PJ, Hitch WL, Walker EM, Hightower AW, Eberhard ML. Maternal filarial infection as risk factor for infection in children. Lancet (1991) 337(8748):1005-6. doi:10.1016/0140-6736(91)92661-K
81. Malhotra I, Mungai PL, Wamachi AN, Tisch D, Kioko JM, Ouma JH, et al. Prenatal T cell immunity to Wuchereria bancrofti and its effect on filarial immunity and infection susceptibility during childhood. J Infect Dis (2006) 193(7):1005-13. doi:10.1086/500472
82. Malhotra I, Ouma JH, Wamachi A, Kioko J, Mungai P, Njzovu M, et al. Influence of maternal filariasis on childhood infection and immunity to Wuchereria bancrofti in Kenya. Infect Immun (2003) 71(9):5231-7. doi:10.1128/IAI.71.9.5231-5237.2003
83. Guadalupe I, Mitre E, Benitez S, Chico ME, Nutman TB, Cooper PJ. Evidence for in utero sensitization to Ascaris lumbricoides in newborns of mothers with ascariasis. J Infect Dis (2009) 199(12):1846-50. doi:10.1086/599214
84. Mehta RS, Rodriguez A, Chico M, Guadalupe I, Broncano N, Sandoval C, et al. Maternal geohelminth infections are associated with an increased susceptibility to geohelminth infection in children: a case-control study. PLoS Negl Trop Dis (2012) 6(7):e1753. doi:10.1371/journal.pntd.0001753
85. MacDonald AS. Immunology of parasitic helminth infections. Infect Immun (2002) 70(2):427-33. doi:10.1128/IAI.70.2.427-433.2002
86. Kamal SM, El Sayed Khalifa K. Immune modulation by helminthic infections: worms and viral infections. Parasite Immunol (2006) 28(10):483-96. doi:10.1111/j.1365-3024.2006.00909.x
87. Cooper PJ, Chico M, Sandoval C, Espinel I, Guevara A, Levine MM, et al. Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin b subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect Immun (2001) 69(3):1574-80. doi:10.1128/IAI.69.3.1574-1580.2001
88. van Riet E, Hartgers FC, Yazdanbakhsh M. Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology (2007) 212(6):475-90. doi:10.1016/j.imbio.2007.03.009
89. Sabin EA, Araujo MI, Carvalho EM, Pearce EJ. Impairment of tetanus toxoid-specific THl-like immune responses in humans infected with Schistosoma mansoni. J Infect Dis (1996) 173(1):269-72. doi:10.1093/infdis/173.1.269
90. Urban JF Jr, Steenhard NR, Solano-Aguilar GI, Dawson HD, Iweala OI, Nagler CR, et al. Infection with parasitic nematodes confounds vaccination efficacy. Vet Parasitol (2007) 148(1):14-20. doi:10.1016/j.vetpar.2007.05.006
91. Gallagher M, Malhotra I, Mungai PL, Wamachi AN, Kioko JM, Ouma JH, et al. The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. AIDS (2005) 19(16):1849-55. doi:10.1097/01.aids.0000189846.90946.5d
92. Gebreegziabiher D, Desta K, Desalegn G, Howe R, Abebe M. The effect of maternal helminth infection on maternal and neonatal immune function and immunity to tuberculosis. PLoS One (2014) 9(4):e93429. doi:10.1371/journal.pone.0093429
93. Slogrove A, Reikie B, Naidoo S, De Beer C, Ho K, Cotton M, et al. HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life. J Trop Pediatr (2012) 58(6):505-8. doi:10.1093/tropej/fms019
94. Afran L, Garcia Knight M, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL. HIV-exposed uninfected children: a growing population with a vulnerable immune system? HEU children: a vulnerable immune system? Clin Exp Immunol (2014) 176(1):11-22. doi:10.1111/cei.12251
95. Reikie BA, Adams RCM, Leligdowicz A, Ho K, Naidoo S, Ruck CE, et al. Altered innate immune development in HIV-exposed uninfected infants. J Acquir Immune Defic Syndr (2014) 66(3):245-55. doi:10.1097/QAI.0000000000000161
96. Reikie BA, Naidoo S, Ruck CE, Slogrove AL, de Beer C, La Grange H, et al. Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life. Clin Vaccine Immunol (2012) 20(1):33-8. doi:10.1128/CVI.00557-12
97. Abramczuk BM, Mazzola TN, Moreno YMF, Zorzeto TQ, Quintilio W, Wolf PS, et al. Impaired humoral response to vaccines among HIV-exposed uninfected infants. Clin Vaccine Immunol (2011) 18(9):1406-9. doi:10.1128/CVI.05065-11
98. Kidzeru EB, Hesseling AC, Passmore J-AS, Myer L, Gamieldien H, Tchakoute CT, et al. In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants. AIDS (2014) 28(10):1421-30. doi:10.1097/QAD.0000000000000292
99. Kakkar F, Lamarre V, Ducruet T, Boucher M, Valois S, Soudeyns H, et al. Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency. BMC Infect Dis (2014) 14(1):236. doi:10.1186/1471-2334-14-236
100. Kuhn L, Meddows-Taylor S, Gray G, Tiemessen C. Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero. Clin Infect Dis (2002) 34(2):267-76. doi:10.1086/338153
101. Arpadi S, Fawzy A, Aldrovandi GM, Kankasa C, Sinkala M, Mwiya M, et al. Growth faltering due to breastfeeding cessation in uninfected children born to HIV-infected mothers in Zambia. Am J Clin Nutr (2009) 90(2):344-53. doi:10.3945/ajcn.2009.27745
102. Kagaayi J, Gray RH, Brahmbhatt H, Kigozi G, Nalugoda F, Wabwire-Mangen F, et al. Survival of infants born to HIV-positive mothers, by feeding modality, in Rakai, Uganda. PLoS One (2008) 3(12):e3877. doi:10.1371/journal.pone.0003877
103. Taha TE, Hoover DR, Chen S, Kumwenda NI, Mipando L, Nkanaunena K, et al. Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi. Clin Infect Dis (2011) 53(4):388-95. doi:10.1093/cid/cir413
104. Coutsoudis A. HIV, infant feeding and more perils for poor people: new WHO guidelines encourage review of formula milk policies. Bull World Health Organ (2008) 86(3):210-4. doi:10.2471/BLT.07.041679
105. Lãnnerdal B. Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr (2003) 77(6):1537S-43S.
106. Garofalo R. Cytokines in human milk. J Pediatr (2010) 156(2):S36-40. doi:10.1016/j.jpeds.2009.11.019
107. Peroni DG, Chirumbolo S, Veneri D, Piacentini GL, Tenero L, Vella A, et al. Colostrum-derived b and T cells as an extra-lymphoid compartment of effector cell populations in humans. J Matern Fetal Neonatal Med (2013) 26(2):137-42. doi:10.3109/14767058.2012.733744
108. Field CJ. The immunological components of human milk and their effect on immune development in infants. J Nutr (2005) 135(1):1-4.
109. Ip S, Chung M, Raman G, Chew P, Magula N, DeVine D, et al. Breastfeeding and maternal and infant health outcomes in developed countries. Evid Rep Technol Assess (Full Rep) (2007) 153:1-186. doi:10.1542/gr.18-2-15
110. Morgan G. What, if any, is the effect of malnutrition on immunological competence? Lancet (1997) 349(9066):1693-5. doi:10.1016/S0140-6736(96)12038-9
111. Chatzi L, Kogevinas M. Prenatal and childhood Mediterranean diet and the development of asthma and allergies in children. Public Health Nutr (2009) 12(9A):1629. doi:10.1017/S1368980009990474
112. West CE, Videky DJ, Prescott SL. Role of diet in the development of immune tolerance in the context of allergic disease. Curr Opin Pediatr (2010) 22(5):635-41. doi:10.1097/MOP.0b013e32833d96ef
113. Calder PC, Krauss-Etschmann S, de Jong EC, Dupont C, Frick J-S, Frokiaer H, et al. Early nutrition and immunity - progress and perspectives. Br J Nutr (2006) 96(4):774-90. doi:10.1079/BJN20061917
114. Bhaskaram P. Micronutrient malnutrition, infection, and immunity: an overview. Nutr Rev (2002) 60:S40-5. doi:10.1301/00296640260130722
115. Kubena K, McMurray DN. Nutrition and the immune system: a review of nutrient-nutrient interactions. J Am Diet Assoc (1996) 96(11):1156-64. doi:10.1016/S0002-8223(96)00297-0
116. Palmer AC. Nutritionally mediated programming of the developing immune system. Adv Nutr (2011) 2(5):377-95. doi:10.3945/an.111.000570
117. Dylewski M, Mastro A, Picciano M. Maternal selenium nutrition and neonatal immune system development. Neonatology (2002) 82(2):122-7. doi:10.1159/000063088
118. Prasad AS. Discovery of human zinc deficiency: its impact on human health and disease. Adv Nutr (2013) 4(2):176-90. doi:10.3945/an.112.003210
119. Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr (2004) 24(1):277-98. doi:10.1146/annurev.nutr.24.012003.132454
120. Black RE. Zinc deficiency, infectious disease and mortality in the developing world. J Nutr (2003) 133(5):1485S-9S.
121. Goldenberg RL. The plausibility of micronutrient deficiency in relationship to perinatal infection. J Nutr (2003) 133(5):1645S-8S.
122. Amarasekera M, Prescott SL, Palmer DJ. Nutrition in early life, immune-programming and allergies: the role of epigenetics. Asian Pac J Allergy Immunol (2013) 31(3):175-82.
123. Roseboom T, de Rooij S, Painter R. The Dutch famine and its long-term consequences for adult health. Early Hum Dev (2006) 82(8):485-91. doi:10.1016/j.earlhumdev.2006.07.001
124. Painter RC, Roseboom TJ, Bleker OP. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol (2005) 20(3):345-52. doi:10.1016/j.reprotox.2005.04.005
125. Veenendaal M, Painter R, de Rooij S, Bossuyt P, van der Post J, Gluckman P, et al. Transgenerational effects of prenatal exposure to the 1944-45 Dutch famine. BJOG (2013) 120(5):548-54. doi:10.1111/1471-0528.12136
126. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol (2011) 29(1):415-45. doi:10.1146/annurev-immunol-031210-101322
127. Kaati G, Bygren LO, Edvinsson S. Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. Eur J Hum Genet (2002) 10(11):682-8. doi:10.1038/sj.ejhg.5200859
128. McDade TW, Beck MA, Kuzawa C, Adair LS. Prenatal undernutrition, postnatal environments, and antibody response to vaccination in adolescence. Am J Clin Nutr (2001) 74(4):543-8.
129. Ghattas H, Wallace DL, Solon JA, Henson SM, Zhang Y, Ngom PT, et al. Long-term effects of perinatal nutrition on T lymphocyte kinetics in young Gambian men. Am J Clin Nutr (2007) 85(2):480-7.
130. Strachan DP. Hay fever, hygiene, and household size. BMJ (1989) 299(6710):1259. doi:10.1136/bmj.299.6710.1259
131. Epstein FH, Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med (2000) 342(20):1500-7. doi:10.1056/NEJM200005183422007
132. Steel JH, Malatos S, Kennea N, Edwards AD, Miles L, Duggan P, et al. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor. Pediatr Res (2005) 57(3):404-11. doi:10.1203/01.PDR.0000153869.96337.90
133. Jiménez E, Fernández L, Marín ML, Martín R, Odriozola JM, Nueno-Palop C, et al. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol (2005) 51(4):270-4. doi:10.1007/s00284-005-0020-3
134. Azad MB, Lissitsyn Y, Miller GE, Becker AB, HayGlass KT, Kozyrskyj AL. Influence of socioeconomic status trajectories on innate immune responsiveness in children. PLoS One (2012) 7(6):e38669. doi:10.1371/journal.pone.0038669
135. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A (2010) 107(26):11971-5. doi:10.1073/pnas.1002601107
136. Neu J, Rushing J. Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesis. Clin Perinatol (2011) 38(2):321-31. doi:10.1016/j.clp.2011.03.008
137. Khafipour E, Ghia J-E. Mode of delivery and inflammatory disorders. J Immunol Clin Res (2013) 1:1104.
138. Malamitsi-Puchner A, Protonotariou E, Boutsikou T, Makrakis E, Sarandakou A, Creatsas G. The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period. Early Hum Dev (2005) 81(4):387-92. doi:10.1016/j.earlhumdev.2004.10.017
139. Fernández L, Langa S, Martín V, Maldonado A, Jiménez E, Martín R, et al. The human milk microbiota: origin and potential roles in health and disease. Pharmacol Res (2013) 69(1):1-10. doi:10.1016/j.phrs.2012.09.001
140. Ward TL, Hosid S, Ioshikhes I, Altosaar I. Human milk metagenome: a functional capacity analysis. BMC Microbiol (2013) 13(1):116. doi:10.1186/1471-2180-13-116
141. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 444(7122):1027-31. doi:10.1038/nature05414
142. Musso G, Gambino R, Cassader M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med (2011) 62(1):361-80. doi:10.1146/annurev-med-012510-175505
143. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science (2013) 341(6150):1241214-1241214. doi:10.1126/science.1241214
144. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol (2009) 9(5):313-23. doi:10.1038/nri2515
145. Sjögren YM, Tomicic S, Lundberg A, Böttcher MF, Björkstén B, Sverremark-Ekström E, et al. Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin Exp Allergy (2009) 39(12):1842-51. doi:10.1111/j.1365-2222.2009.03326.x
146. Smith MI, Yatsunenko T, Manary MJ, Trehan I, Mkakosya R, Cheng J, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science (2013) 339(6119):548-54. doi:10.1126/science.1229000
147. Finucane MM, Sharpton TJ, Laurent TJ, Pollard KS. A taxonomic signature of obesity in the microbiome? Getting to the guts of the matter. PLoS One (2014) 9(1):e84689. doi:10.1371/journal.pone.0084689
148. Sze MA, Dimitriu PA, Hayashi S, Elliott WM, McDonough JE, Gosselink JV, et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 185(10):1073-80. doi:10.1164/rccm.201111-2075OC
149. Greenblum S, Turnbaugh PJ, Borenstein E. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci U S A (2012) 109(2):594-9. doi:10.1073/pnas.1116053109
150. Meurens F, Berri M, Siggers RH, Willing BP, Salmon H, Van Kessel AG, et al. Commensal bacteria and expression of two major intestinal chemokines, TECK/CCL25 and MEC/CCL28, and their receptors. PLoS One (2007) 2(7):e677. doi:10.1371/journal.pone.0000677
151. Prescott SL. Early-life environmental determinants of allergic diseases and the wider pandemic of inflammatory noncommunicable diseases. J Allergy Clin Immunol (2013) 131(1):23-30. doi:10.1016/j.jaci.2012.11.019
152. Spor A, Koren O, Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol (2011) 9(4):279-90. doi:10.1038/nrmicro2540
153. Ifrim DC, Quintin J, Joosten LAB, Jacobs C, Jansen T, Jacobs L, et al. Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors. Clin Vaccine Immunol (2014) 21(4):534-45. doi:10.1128/CVI.00688-13
154. Levy O, Netea MG. Innate immune memory: implications for development of pediatric immunomodulatory agents and adjuvanted vaccines. Pediatr Res (2014) 75(1-2):184-8. doi:10.1038/pr.2013.214
155. Burl S, Townend J, Njie-Jobe J, Cox M, Adetifa UJ, Touray E, et al. Age-dependent maturation of toll-like receptor-mediated cytokine responses in Gambian infants. PLoS One (2011) 6(4):e18185. doi:10.1371/journal.pone.0018185
156. Lisciandro JG, Prescott SL, Nadal-Sims MG, Devitt CJ, Pomat W, Siba PM, et al. Ontogeny of toll-like and NOD-like receptor-mediated innate immune responses in Papua New Guinean infants. PLoS One (2012) 7(5):e36793. doi:10.1371/journal.pone.0036793
157. Smolen KK, Ruck CE, Fortuno ES, Ho K, Dimitriu P, Mohn WW, et al. Pattern recognition receptor-mediated cytokine response in infants across 4 continents. J Allergy Clin Immunol (2014) 133(3):818.e-26.e. doi:10.1016/j.jaci.2013.09.038
158. Brewer TF. Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin Infect Dis (2000) 31(Suppl 3):S64-7. doi:10.1086/314072
159. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet (1995) 346(8986):1339-45. doi:10.1016/S0140-6736(95)92348-9
160. Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PEM, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis (2014) 58(4):470-80. doi:10.1093/cid/cit790
161. Kernodle DS. Decrease in the effectiveness of bacille Calmette-Guérin vaccine against pulmonary tuberculosis: a consequence of increased immune suppression by microbial antioxidants, not overattenuation. Clin Infect Dis (2010) 51(2):177-84. doi:10.1086/653533
162. Black GF, Dockrell HM, Crampin AC, Floyd S, Weir RE, Bliss L, et al. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in Northern Malawi. J Infect Dis (2001) 184(3):322-9. doi:10.1086/322042
163. Lalor MK, Floyd S, Gorak-Stolinska P, Ben-Smith A, Weir RE, Smith SG, et al. BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. J Infect Dis (2011) 204(7):1075-85. doi:10.1093/infdis/jir515
164. Ritz N, Hanekom WA, Robins-Browne R, Britton WJ, Curtis N. Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiol Rev (2008) 32(5):821-41. doi:10.1111/j.1574-6976.2008.00118.x
165. Wu B, Huang C, Garcia L, de Leon AP, Osornio JS, Bobadilla-del Valle M, et al. Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin. Infect Immun (2007) 75(7):3658-64. doi:10.1128/IAI.00244-07
166. Biering-Sørensen S, Aaby P, Napirna BM, Roth A, Ravn H, Rodrigues A, et al. Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact. Pediatr Infect Dis J (2012) 31(3):306-8. doi:10.1097/INF.0b013e3182458289
167. Ritz N, Mui M, Balloch A, Curtis N. Non-specific effect of bacille Calmette-Guérin vaccine on the immune response to routine immunisations. Vaccine (2013) 31(30):3098-103. doi:10.1016/j.vaccine.2013.03.059
168. Shann F. Nonspecific effects of vaccines and the reduction of mortality in children. Clin Ther (2013) 35(2):109-14. doi:10.1016/j.clinthera.2013.01.007
169. Gaayeb L, Pinçon C, Cames C, Sarr JB, Seck M, Schacht AM, et al. Immune response to Bordetella pertussis is associated with season and undernutrition in Senegalese children. Vaccine (2014) 32(27):3431-7. doi:10.1016/j.vaccine.2014.03.086
170. Lisse IM, Aaby P, Whittle H, Jensen H, Engelmann M, Christensen LB. T-lymphocyte subsets in West African children: impact of age, sex, and season. J Pediatr (1997) 130(1):77-85. doi:10.1016/S0022-3476(97)70313-5
171. Collinson AC, Ngom PT, Moore SE, Morgan G, Prentice AM. Birth season and environmental influences on blood leucocyte and lymphocyte subpopulations in rural Gambian infants. BMC Immunol (2008) 9(1):18. doi:10.1186/1471-2172-9-18
172. Moore SE, Cole TJ, Collinson AC, Poskitt EM, McGregor IA, Prentice AM. Prenatal or early postnatal events predict infectious deaths in young adulthood in rural Africa. Int J Epidemiol (1999) 28(6):1088-95. doi:10.1093/ije/28.6.1088
173. Moore SE, Collinson AC, Prentice AM. Immune function in rural Gambian children is not related to season of birth, birth size, or maternal supplementation status. Am J Clin Nutr (2001) 74(6):840-7.
174. Disanto G, Chaplin G, Morahan J, Giovannoni G, Hyppönen E, Ebers G, et al. Month of birth, vitamin D and risk of immune-mediated disease: a case control study. BMC Med (2012) 10(1):69. doi:10.1186/1741-7015-10-69
175. Martineau AR, Nhamoyebonde S, Oni T, Rangaka MX, Marais S, Bangani N, et al. Reciprocal seasonal variation in vitamin d status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci U S A (2011) 108(47):19013-7. doi:10.1073/pnas.1111825108
176. Panigrahi P, Parida S, Pradhan L, Nanda N, Satpathy R, Chandel D, et al. Effectiveness of a Lactobacillus plantarum synbiotic therapy for preventing late onset sepsis in neonates [abstract]. Pediatric Academic Societies Annual Meeting. Washington, DC (2013).
177. de Wit R, Bouvier T. 'Everything is everywhere, but, the environment selects'; what did Baas Becking and Beijerinck really say? Environ Microbiol (2006) 8(4):755-8. doi:10.1111/j.1462-2920.2006.01017.x